Eyebright Historical Income Statement

688050 Stock

90.61 1.90 2.05%

Historical analysis of Eyebright Medical income statement accounts such as Interest Expense of 10.3 M, Selling General Administrative of 226.9 M or Selling And Marketing Expenses of 130.4 M can show how well Eyebright Medical Technology performed in making a profits. Evaluating Eyebright Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Eyebright Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Eyebright Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Eyebright Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Eyebright Income Statement Analysis

Eyebright Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Eyebright Medical shareholders. The income statement also shows Eyebright investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Eyebright Medical Income Statement Chart

At present, Eyebright Medical's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 10.3 M, whereas Tax Provision is forecasted to decline to about 25.8 M.

Depreciation And Amortization Interest Expense Selling General Administrative Total Revenue Minority Interest

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts Eyebright Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Eyebright Medical Technology whose combined shares represent less than 50% of the total outstanding shares issued by Eyebright Medical have a minority interest in Eyebright Medical.

Most accounts from Eyebright Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Eyebright Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Interest Expense	736.9K	2.0M	9.8M	10.3M
Depreciation And Amortization	42.0M	58.7M	67.5M	70.9M

Interest Expense Depreciation And Amortization

Eyebright Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation	Minority Interest
Depreciation And Amortization		0.75	0.77	1.0	0.98	0.99	1.0	1.0	1.0	0.99	1.0	0.92	0.92	1.0	0.25	1.0	0.99	0.93	-0.81	0.73	0.93	0.85	0.86
Interest Expense	0.75		0.99	0.75	0.87	0.84	0.75	0.78	0.75	0.83	0.75	0.95	0.94	0.78	0.45	0.79	0.78	0.69	-0.99	0.71	0.73	0.83	0.98
Selling General Administrative	0.77	0.99		0.77	0.89	0.86	0.77	0.8	0.77	0.85	0.77	0.96	0.96	0.79	0.38	0.81	0.79	0.69	-0.98	0.77	0.73	0.83	0.98
Selling And Marketing Expenses	1.0	0.75	0.77		0.98	0.99	1.0	1.0	1.0	0.99	1.0	0.91	0.92	1.0	0.27	1.0	0.98	0.93	-0.8	0.75	0.93	0.84	0.86
Total Revenue	0.98	0.87	0.89	0.98		1.0	0.98	0.99	0.98	1.0	0.98	0.98	0.98	0.99	0.32	0.99	0.98	0.91	-0.9	0.79	0.92	0.89	0.94
Gross Profit	0.99	0.84	0.86	0.99	1.0		0.99	0.99	0.99	1.0	0.99	0.96	0.97	0.99	0.31	1.0	0.99	0.92	-0.88	0.78	0.93	0.88	0.92
Other Operating Expenses	1.0	0.75	0.77	1.0	0.98	0.99		1.0	1.0	0.99	1.0	0.92	0.92	1.0	0.26	1.0	0.99	0.94	-0.8	0.75	0.94	0.85	0.86
Operating Income	1.0	0.78	0.8	1.0	0.99	0.99	1.0		1.0	1.0	1.0	0.93	0.93	1.0	0.28	1.0	0.99	0.94	-0.83	0.76	0.94	0.86	0.88
Ebit	1.0	0.75	0.77	1.0	0.98	0.99	1.0	1.0		0.99	1.0	0.91	0.92	1.0	0.28	1.0	0.99	0.94	-0.8	0.74	0.94	0.85	0.86
Research Development	0.99	0.83	0.85	0.99	1.0	1.0	0.99	1.0	0.99		0.99	0.96	0.96	1.0	0.33	1.0	0.99	0.93	-0.87	0.78	0.93	0.88	0.92
Ebitda	1.0	0.75	0.77	1.0	0.98	0.99	1.0	1.0	1.0	0.99		0.91	0.92	1.0	0.28	1.0	0.99	0.94	-0.8	0.74	0.94	0.85	0.86
Cost Of Revenue	0.92	0.95	0.96	0.91	0.98	0.96	0.92	0.93	0.91	0.96	0.91		1.0	0.93	0.37	0.94	0.92	0.84	-0.96	0.81	0.86	0.89	0.99
Total Operating Expenses	0.92	0.94	0.96	0.92	0.98	0.97	0.92	0.93	0.92	0.96	0.92	1.0		0.93	0.36	0.94	0.93	0.84	-0.96	0.81	0.86	0.89	0.99
Income Before Tax	1.0	0.78	0.79	1.0	0.99	0.99	1.0	1.0	1.0	1.0	1.0	0.93	0.93		0.3	1.0	0.99	0.94	-0.83	0.75	0.94	0.86	0.88
Total Other Income Expense Net	0.25	0.45	0.38	0.27	0.32	0.31	0.26	0.28	0.28	0.33	0.28	0.37	0.36	0.3		0.31	0.29	0.32	-0.45	0.16	0.36	0.37	0.43
Net Income	1.0	0.79	0.81	1.0	0.99	1.0	1.0	1.0	1.0	1.0	1.0	0.94	0.94	1.0	0.31		0.99	0.94	-0.84	0.76	0.94	0.87	0.89
Income Tax Expense	0.99	0.78	0.79	0.98	0.98	0.99	0.99	0.99	0.99	0.99	0.99	0.92	0.93	0.99	0.29	0.99		0.95	-0.83	0.71	0.94	0.86	0.87
Tax Provision	0.93	0.69	0.69	0.93	0.91	0.92	0.94	0.94	0.94	0.93	0.94	0.84	0.84	0.94	0.32	0.94	0.95		-0.75	0.65	0.99	0.92	0.79
Net Interest Income	-0.81	-0.99	-0.98	-0.8	-0.9	-0.88	-0.8	-0.83	-0.8	-0.87	-0.8	-0.96	-0.96	-0.83	-0.45	-0.84	-0.83	-0.75		-0.68	-0.79	-0.87	-0.99
Interest Income	0.73	0.71	0.77	0.75	0.79	0.78	0.75	0.76	0.74	0.78	0.74	0.81	0.81	0.75	0.16	0.76	0.71	0.65	-0.68		0.69	0.71	0.77
Net Income From Continuing Ops	0.93	0.73	0.73	0.93	0.92	0.93	0.94	0.94	0.94	0.93	0.94	0.86	0.86	0.94	0.36	0.94	0.94	0.99	-0.79	0.69		0.94	0.83
Reconciled Depreciation	0.85	0.83	0.83	0.84	0.89	0.88	0.85	0.86	0.85	0.88	0.85	0.89	0.89	0.86	0.37	0.87	0.86	0.92	-0.87	0.71	0.94		0.88
Minority Interest	0.86	0.98	0.98	0.86	0.94	0.92	0.86	0.88	0.86	0.92	0.86	0.99	0.99	0.88	0.43	0.89	0.87	0.79	-0.99	0.77	0.83	0.88

Click cells to compare fundamentals

Eyebright Medical Account Relationship Matchups

Eyebright Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	26.2M	29.4M	42.0M	58.7M	67.5M	70.9M
Interest Expense	160.5K	2.6K	736.9K	2.0M	9.8M	10.3M
Selling General Administrative	10.0M	10.2M	18.1M	22.3M	216.1M	226.9M
Selling And Marketing Expenses	50.4M	57.3M	89.9M	108.0M	124.2M	130.4M
Total Revenue	195.2M	273.0M	433.1M	579.5M	951.2M	998.7M
Gross Profit	167.3M	229.1M	365.0M	491.1M	722.9M	759.1M
Other Operating Expenses	130.0M	169.7M	265.5M	331.3M	381.0M	400.1M
Operating Income	69.7M	111.3M	185.0M	259.3M	328.3M	344.7M
Ebit	69.7M	111.3M	185.0M	259.3M	298.2M	313.1M
Research Development	21.7M	30.0M	51.9M	66.0M	93.6M	98.3M
Ebitda	95.8M	140.7M	227.0M	318.0M	365.7M	384.0M
Cost Of Revenue	27.9M	43.9M	68.0M	88.4M	228.2M	239.6M
Total Operating Expenses	102.0M	125.8M	197.4M	243.0M	622.9M	654.0M
Income Before Tax	69.7M	111.0M	187.8M	264.1M	327.7M	344.1M
Total Other Income Expense Net	1.1K	(217.9K)	2.8M	4.8M	5.5M	5.8M
Net Income	66.7M	96.6M	171.3M	232.7M	304.0M	319.2M
Income Tax Expense	3.9M	14.9M	20.0M	36.8M	42.4M	44.5M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Eyebright Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Eyebright Historical Income Statement

About Eyebright Income Statement Analysis

Eyebright Medical Income Statement Chart

Depreciation And Amortization

Interest Expense

Total Revenue

Minority Interest

Eyebright Medical income statement Correlations

Eyebright Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Eyebright Medical income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Eyebright Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Selling And Marketing Expenses	+ 1.0	Depreciation And Amortization
Other Operating Expenses	+ 1.0	Depreciation And Amortization
Operating Income	+ 1.0	Depreciation And Amortization
Ebit	+ 1.0	Depreciation And Amortization
Ebitda	+ 1.0	Depreciation And Amortization
Income Before Tax	+ 1.0	Depreciation And Amortization

Minority Interest	- 0.99	Net Interest Income
Net Interest Income	- 0.99	Interest Expense
Net Interest Income	- 0.98	Selling General Administrative
Net Interest Income	- 0.96	Total Operating Expenses
Net Interest Income	- 0.96	Cost Of Revenue
Net Interest Income	- 0.9	Total Revenue